Anti-VEGF therapy is effective for neovascular age ... and understanding this concept is central to therapy. Lesion type may affect response to therapy and entities such as polypoidal choroidal ...

The author described in detail the vasculature of several tumours that spontaneously occur in rats, and observed that the vascular architecture of each tumour type ... of an anti-VEGF monoclonal ...

Two independent studies show that ephrin-B2 controls the internalization and signaling of two types of vascular endothelial growth factor (VEGF) receptors—thereby regulating VEGF-induced ...

The following is a summary of “Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration,” published in the March 2025 issue of British Journal ...

The trial will explore CS2009 in treating various types of advanced solid tumours ... as well as robust synergistic effect with anti-VEGF activity; in immunocompetent mouse models, CS2009 showed ...

Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at Angiogenesis, Exudation, and Degeneration 2025. Older patients with ...

SUZHOU, China, March 3, 2025 /PRNewswire/ --CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer ...